Your browser doesn't support javascript.
loading
High-Throughput Screening Identifies Idasanutlin as a Resensitizing Drug for Venetoclax-Resistant Neuroblastoma Cells.
Vernooij, Lindy; Bate-Eya, Laurel T; Alles, Lindy K; Lee, Jasmine Y; Koopmans, Bianca; Jonus, Hunter C; Schubert, Nil A; Schild, Linda; Lelieveld, Daphne; Egan, David A; Kerstjens, Mark; Stam, Ronald W; Koster, Jan; Goldsmith, Kelly C; Molenaar, Jan J; Dolman, M Emmy M.
Afiliación
  • Vernooij L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Bate-Eya LT; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Alles LK; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Lee JY; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Koopmans B; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Jonus HC; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Schubert NA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Schild L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Lelieveld D; Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Egan DA; Department of Cell Biology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Kerstjens M; Department of Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
  • Stam RW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Koster J; Department of Oncogenomics, Amsterdam UMC, location AMC, Amsterdam, the Netherlands.
  • Goldsmith KC; Department of Pediatrics, Emory University, Aflac Cancer and Blood Disorders Center at the Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
  • Dolman MEM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. memdolman@gmail.com.
Mol Cancer Ther ; 20(6): 1161-1172, 2021 06.
Article en En | MEDLINE | ID: mdl-33850004
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirrolidinas / Proteínas Proto-Oncogénicas c-mdm2 / Ensayos Analíticos de Alto Rendimiento / Para-Aminobenzoatos / Neuroblastoma Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Pirrolidinas / Proteínas Proto-Oncogénicas c-mdm2 / Ensayos Analíticos de Alto Rendimiento / Para-Aminobenzoatos / Neuroblastoma Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos